Related references
Note: Only part of the references are listed.Functional selectivity through protean and biased agonism: Who steers the ship?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2007)
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study
Robert Kerwin et al.
EUROPEAN PSYCHIATRY (2007)
Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia:: A triple tracer PET study
David Mamo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for anti psychotic-induced hyperprolactinemia: A placebo-controlled trial
Joo-Cheol Shim et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
GPCR functional selectivity has therapeutic impact
Richard B. Mailman
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling
Shaun Jordan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response -: A double-blind PET study in schizophrenia
Ofer Agid et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Aripiprazole has functionally selective actions at dopamine D-2 receptor-mediated signaling pathways
Jonathan D. Urban et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine
Robert M. Kessler et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia
G Gründer et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol
RM Kessler et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal, healthy volunteers
S Mallikaarjun et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
JK Seamans et al.
PROGRESS IN NEUROBIOLOGY (2004)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulation study based on experimental data
H Olsson et al.
NEUROIMAGE (2001)
No support for regional selectivity in clozapine-treated patients:: A PET study with [11C]raclopride and [11C]FLB 457
M Talvik et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
In vitro extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia
X Xiberas et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
A Abi-Dargham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
